This case details the introduction of liquid biopsy technology, an innovative non-invasive cancer test that looks for tumor cells and pieces of tumor cells DNA circulating in the blood. The note explores the development of liquid biopsy as an alternative to other cancer screening methods and outlines the market landscape, impact on outcomes, leading companies, and future potential of the technology.
